|
News & Information |
|
Prostate / Prostate Cancer News From Medical News Today
|
Latest Health News and Medical News posted throughout the day, every day.
|
-
CytRx Initiates Phase 2 Clinical Trial With Bafetinib In Advanced Prostate Cancer
CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company specializing in oncology, today announced initiation of the PROstate Advanced Cancer Treatment (PROACT) Phase 2 proof-of-concept clinical trial to evaluate the efficacy and safety of bafetinib in patients with advanced prostate cancer...
-
New Model May Simplify High-Dose Radiosurgery Planning
There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, which is used to treat brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers. Radiation oncologists at the Ohio State University Comprehensive Cancer Center-Arthur G...
-
Light The White House Blue For Prostate Cancer Awareness Month
Members of the Prostate Cancer Roundtable, consisting of America's Leading Prostate Cancer Organizations, are asking President Obama to place a blue ribbon on the White House and light the White House blue in the evenings in recognition of Prostate Cancer Awareness Month in September. This visible show of support for prostate cancer awareness by the White House will be a major tribute to the 2...
-
CyberKnife Treatment For Prostate Cancer
CyberKnife radiosurgery treatment for prostate cancer is rapid, effective and has no side effects, with the added benefit of being non-invasive. Since 2003, the CyberKnife Center of Miami and the CyberKnife Center of Palm Beach have been providing this high tech cancer treatment longer than any facility in South Florida...
-
InSightec Treats First Prostate Cancer Patients In Clinical Trials
nSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients. Seven patients with localized low-risk prostate cancer were treated worldwide so far...
-
Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients In Clinical Trials
Elbit Imaging Ltd. (NASDAQ: EMITF) ("Elbit" "Company") that it's subsidiary, InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients...
-
Atrazine Causes Prostate Inflammation In Male Rats And Delays Puberty
A new study shows that male rats prenatally exposed to low doses of atrazine, a widely used herbicide, are more likely to develop prostate inflammation and to go through puberty later than non-exposed animals. The research adds to a growing body of literature on atrazine, an herbicide predominantly used to control weeds and grasses in crops such as corn and sugar cane...
-
Prostate Cancer Treatment Expert Dr. David Samadi, MD Discusses Preventive Medicine Versus Treatment Or Outcome-Based Medicine
Starting in September, President Obama's Affordable Care Act will go into effect. The act mandates free preventative services such as cholesterol or breast cancer screenings and tetanus shots...
-
Familial Prostate Cancer Risk Could Be Inflated By Increased Diagnosis Seeking
A new study from Sweden suggests that the of risk of prostate cancer in men with a known family history of the disease could be inflated because such men are more likely to seek a diagnosis, further intensifying the controversial debate on whether PSA testing does more harm than good...
-
Cost Of Prostate Cancer Care Caries With Initial Treatment Choice
A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study finds that treatments that may be less expensive in the short-term may have higher long-term costs...
|
|
News & Information 
